Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer.

Autor: Shimizu, Yasuomi1, Iguchi, Taro1, Tamada, Satoshi1 s-tamada@med.osaka-cu.ac.jp, Yasuda, Sayaka1, Kato, Minoru1, Ninomiya, Noriko1, Yamasaki, Takeshi1, Nakatani, Tatsuya1
Zdroj: Molecular & Clinical Oncology. 2018, Vol. 8 Issue 6, p791-796. 6p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje